Acorah Software Products - Accounts Production 16.5.460 false true false true No description of principal activity 25 April 2024 30 April 2025 30 April 2025 15680904 Dr Srividya Seshadri iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15680904 2024-04-24 15680904 2025-04-30 15680904 2024-04-25 2025-04-30 15680904 frs-core:CurrentFinancialInstruments 2025-04-30 15680904 frs-bus:PrivateLimitedCompanyLtd 2024-04-25 2025-04-30 15680904 frs-bus:FilletedAccounts 2024-04-25 2025-04-30 15680904 frs-bus:Micro-entities 2024-04-25 2025-04-30 15680904 frs-bus:AuditExempt-NoAccountantsReport 2024-04-25 2025-04-30 15680904 frs-bus:Director1 2024-04-25 2025-04-30
Registered number: 15680904
Apex Reproductive Health Care 117 Limited
Unaudited Financial Statements
For The Year Ended 30 April 2025
Price Mann Limited
Chartered Certified Accountants
Magnolia House, Spring Villa
11 Spring Villa Road
Edgware
HA8 7EB
Balance Sheet
Registered number: 15680904
2025
£
Current assets 45,471
Creditors: Amounts Falling Due Within One Year (10,557 )
NET CURRENT ASSETS 34,914
TOTAL ASSETS LESS CURRENT LIABILITIES 34,914
NET ASSETS 34,914
CAPITAL AND RESERVES 34,914

Notes

1. General Information
Apex Reproductive Health Care 117 Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15680904 . The registered office is Magnolia House, Spring Villa Park, 11 Spring Villa Road, Edgware, HA8 7EB.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
Page 0
Page 1
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Srividya Seshadri
Director
2 September 2025